In JZLGD-treated NAFLD rats, IL-1β, IL-18, TNF-α, and IL-6 levels were significantly decreased, illustrating that JZLGD inhibits hepatocyte inflammation and prevents the progression of NAFLD. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.